Publications by authors named "Jikui Xie"

Article Synopsis
  • Early-onset Alzheimer's disease (EOAD) shows significant variability compared to late-onset Alzheimer's disease (LOAD), and the underlying biological processes are not fully understood.
  • The study utilized mass spectrometry and machine learning to analyze cerebrospinal fluid (CSF) proteins from a Chinese cohort to discover biomarkers and pathways linked to EOAD.
  • Three promising EOAD biomarkers (SH3BGRL3, LRP8, and LY6 H) were identified, with SH3BGRL3 also validating in a Western cohort, suggesting EOAD may be more related to synaptic dysfunction than LOAD.
View Article and Find Full Text PDF

Objective: To investigate the automatic synthesis of β-amyloid (Aβ) positron emission tomography (PET) imaging agent (E) -4- (2- (6- (2- (2-F fluoroethoxy) ethoxy) ethoxy) pyridine-3-yl) vinyl) - N-methylaniline (F-AV-45) for the diagnosis of Alzheimer's disease (AD) and its clinical application in AD patients.

Materials And Methods: Fluorine-18-AV-45 was synthesized with AV-105 as the precursor, and the factors affecting the synthesis efficiency, such as the amount of precursor, nucleophilic reaction temperature were studied. At the same time, F-AV-45 PET/computed tomography (CT) brain scanning was performed in 15 patients with dementia to determine whether AD was the cause of the dementia.

View Article and Find Full Text PDF

Blood-based biomarkers have been considered as a promising method for the diagnosis of Alzheimer's disease (AD). The reliability and accuracy of plasma core AD biomarkers, including phosphorylated tau (P-tau181), total tau (T-tau), Aβ42, and Aβ40, have also been confirmed in diagnosing AD and predicting cerebral β-amyloid (Aβ) deposition in Western populations, while fewer research studies have ever been conducted in China's Han population. In this study, we investigated the capability of plasma core AD biomarkers in predicting cerebral Aβ deposition burden among the China Aging and Neurodegenerative Disorder Initiative (CANDI) cohort consisting of cognitively normal (CN), mild cognitive impairment (MCI), AD dementia, and non-Alzheimer's dementia disease (Non-ADD).

View Article and Find Full Text PDF

[F]BAY-94-9172, [F]AV-45, and [F]GE-067 were FDA approved positron emission tomography (PET) imaging radiotracer of β-amyloid plaques (Aβ) in Alzheimer's disease (AD). However, the radiochemical synthesis requires multi-step reactions and complex procedure. Recently, a protocol for radiochemical synthesis of sulfur fluoride exchange (SuFEx) using ultrafast F/F isotopic exchange had been reported.

View Article and Find Full Text PDF

The current diagnoses of Alzheimer's disease (AD) mainly rely on such measures as amyloid-β (Aβ) and tau neuropathology biomarkers in vivo via cerebrospinal fluid (CSF) and positron emission tomography (PET) imaging, which had been systematically studied in Caucasian individuals, whereas diagnostic performances of these approaches in Chinese dementia population still remain unclear. This study investigated the associations between the levels of CSF core AD biomarkers, including phosphorylated tau (p-Tau181), total tau (t-Tau), Aβ42, and Aβ40 measured by the single-molecule array (Simoa) and cerebral Aβ deposition status assessed by F-Florbetapir PET (Aβ PET), and evaluated the predictive values of CSF core AD biomarkers in discriminating Aβ PET status in a clinical dementia cohort of the Chinese population, which consisted of patients with mild cognitive impairment (MCI), AD dementia, and non-Alzheimer's dementia disease (Non-ADD). Global standard uptake value ratios (SUVRs) were calculated by Aβ PET, which was divided into positive (Aβ+) and negative (Aβ-) through visual analysis.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a common autoimmune disease characterized by chronic synovial inflammation, which ultimately leads to joint deformity and dysfunction. [F]-GE-180 is a specific PET tracer of the 18 kDa translocator protein (TSPO), which is overexpressed on activated macrophages, and proposed as a biomarker of inflammation. Our study addresses the need to streamline the automatic synthesis of [F]-GE-180 to make it more accessible for routine production and widespread clinical evaluation and application.

View Article and Find Full Text PDF

Objective: To investigate the characteristics of F-FDG PET/CT images of multiple myeloma secondary extramedullary infiltration in order to improve recognition.

Methods: Twenty-one patients with multiple myeloma secondary extramedullary infiltration confirmed by pathology or follow-up from January 2012 to October 2020 in the First Affiliated Hospital of University of Science and Technology of China were retrospectively analyzed. All the patients underwent F-FDG PET/CT imaging before treatment, and the PET/CT characteristics of extramedullary infiltration and bone marrow were analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on (S)-[F]28, a new and effective radiopharmaceutical for detecting Alzheimer's disease using PET imaging.
  • - Researchers successfully automated the synthesis of (S)-[F]28, achieving high yields and purity, making it easier to produce in existing PET facilities.
  • - The developed method aims to support large-scale clinical trials to increase the use of (S)-[F]28 in Alzheimer's research and diagnosis.
View Article and Find Full Text PDF

The aim of this study was to evaluate the association between macrophage migration inhibitory factor (MIF) -173G/C (rs755622), mannose-binding lectin (MBL2) exon 1 codon 54 (rs1800450) gene polymorphisms and rheumatoid arthritis (RA) susceptibility in ethnically different populations. A meta-analysis was conducted (allelic contrast, the additive model, the dominant model and the recessive model) on the MIF-173G/C polymorphism across five studies (four European and one Asian studies), and the MBL2 codon 54 polymorphism with five studies (four Asian and one European studies), respectively. Meta-analysis indicated an association between the MIF-173G/C in all study subjects in allelic contrast (OR=1.

View Article and Find Full Text PDF